{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670321179216896.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1074/jbc.m111.266940"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0021925820535412?httpAccept=text/xml"}},{"identifier":{"@type":"URI","@value":"https://api.elsevier.com/content/article/PII:S0021925820535412?httpAccept=text/plain"}},{"identifier":{"@type":"URI","@value":"https://syndication.highwire.org/content/doi/10.1074/jbc.M111.266940"}}],"dc:title":[{"@value":"Cardiac Hypertrophy Is Positively Regulated by MicroRNA miR-23a"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1383670321179216896","@type":"Researcher","foaf:name":[{"@value":"Kun Wang"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670321179216898","@type":"Researcher","foaf:name":[{"@value":"Zhi-Qiang Lin"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670321179216897","@type":"Researcher","foaf:name":[{"@value":"Bo Long"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670321179216901","@type":"Researcher","foaf:name":[{"@value":"Jian-Hui Li"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670321179216900","@type":"Researcher","foaf:name":[{"@value":"Jing Zhou"}]},{"@id":"https://cir.nii.ac.jp/crid/1383670321179216899","@type":"Researcher","foaf:name":[{"@value":"Pei-Feng Li"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"00219258"}],"prism:publicationName":[{"@value":"Journal of Biological Chemistry"}],"dc:publisher":[{"@value":"Elsevier BV"}],"prism:publicationDate":"2012-01","prism:volume":"287","prism:number":"1","prism:startingPage":"589","prism:endingPage":"599"},"reviewed":"false","dc:rights":["https://www.elsevier.com/tdm/userlicense/1.0/","http://creativecommons.org/licenses/by/4.0/"],"url":[{"@id":"https://api.elsevier.com/content/article/PII:S0021925820535412?httpAccept=text/xml"},{"@id":"https://api.elsevier.com/content/article/PII:S0021925820535412?httpAccept=text/plain"},{"@id":"https://syndication.highwire.org/content/doi/10.1074/jbc.M111.266940"}],"createdAt":"2011-11-15","modifiedAt":"2022-01-05","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360294643740536832","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Anti-tumor activity of the pan-RAF inhibitor TAK-580 in combination with KPT-330 (selinexor) in multiple myeloma"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205225941888","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"microRNA-10a Targets T-box 5 to Inhibit the Development of Cardiac Hypertrophy"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1074/jbc.m111.266940"},{"@type":"CROSSREF","@value":"10.1536/ihj.16-020_references_DOI_JM6PD9kal2S7x2OLx23t8EZNTpv"},{"@type":"CROSSREF","@value":"10.1007/s12185-021-03244-1_references_DOI_JM6PD9kal2S7x2OLx23t8EZNTpv"}]}